NICE has recommended dupilumab, a first-of-its-kind targeted COPD treatment that reduces flare-ups and improves lung function ...

NICE has estimated that around 40% of people with COPD have elevated blood levels of eosinophils and, if half the eligible ...

The National Institute for Health and Care Excellence (NICE), has published final draft guidance recommending dupilumab as a ...

Men and women with chronic obstructive pulmonary disease (COPD), bronchiectasis, and nontuberculous mycobacterial (NTM) lung disease report differences in symptoms, mental health, disease burden, and ...

Diseases linked to cigarette smoke and pollution may be increasing amid the pandemic. Chronic obstructive pulmonary disease (COPD), mainly caused by smoking cigarette smoke and pollution, is the third ...

Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality globally. Effective management hinges on early diagnosis, which is often impeded by non-specific symptoms and ...

COPD and gastrointestinal diseases have a significant bidirectional association, with depressive symptoms serving as a key mediator.

Chronic obstructive pulmonary disease (COPD) is a group of diseases that affect the lungs. The disease makes it difficult to breath and progressively gets worse. About 15 million Americans have been ...

Chronic obstructive pulmonary disorder (COPD) is a group of lung diseases that includes chronic bronchitis and emphysema. Smoking or exposure to air pollutants usually causes COPD. It is becoming ...

Chronic obstructive pulmonary disease (COPD) is more likely to conjure images of breathlessness rather than weak muscles, but can COPD also cause muscle weakness? Research seems to show a correlation.